2022-01-12 |
2022-01-10 |
S
Sale
|
Wolchko J Scott
President and CEO
Executive Director
|
13,161
-2.7%
46.36
610,144
USD
|
13,161
-2.7%
|
46.36
|
610,144
USD
|
|
2022-01-12 |
2022-01-10 |
S
Sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
351
-0.2%
47.17
16,557
USD
|
351
-0.2%
|
47.17
|
16,557
USD
|
|
2022-01-12 |
2022-01-10 |
S
Sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
5,245
-3.3%
46.33
243,001
USD
|
5,245
-3.3%
|
46.33
|
243,001
USD
|
|
2022-01-12 |
2022-01-10 |
S
Sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
643
-0.4%
47.15
30,317
USD
|
643
-0.4%
|
47.15
|
30,317
USD
|
|
2022-01-12 |
2022-01-10 |
S
Sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
7,095
-4.2%
46.37
328,995
USD
|
7,095
-4.2%
|
46.37
|
328,995
USD
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
861
-0.5%
60.31
51,927
USD
|
861
-0.5%
|
60.31
|
51,927
USD
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
27,812
-14.1%
59.86
1,664,826
USD
|
27,812
-14.1%
|
59.86
|
1,664,826
USD
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
16,900
-7.9%
58.84
994,396
USD
|
16,900
-7.9%
|
58.84
|
994,396
USD
|
|
2022-01-04 |
2022-01-03 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
4,427
-2.0%
57.76
255,704
USD
|
4,427
-2.0%
|
57.76
|
255,704
USD
|
|
2021-12-21 |
2021-12-20 |
PS
Planned sale
|
Dulac Edward J III
Chief Financial Officer
Officer
|
15,977
-12.6%
60.00
958,620
USD
|
15,977
-12.6%
|
60.00
|
958,620
USD
|
|
2021-12-14 |
2021-12-13 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
1,600
-1.0%
49.27
78,832
USD
|
1,600
-1.0%
|
49.27
|
78,832
USD
|
|
2021-12-14 |
2021-12-13 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
7,718
-4.6%
48.75
376,253
USD
|
7,718
-4.6%
|
48.75
|
376,253
USD
|
|
2021-12-14 |
2021-12-13 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
6,564
-3.8%
47.61
312,512
USD
|
6,564
-3.8%
|
47.61
|
312,512
USD
|
|
2021-12-14 |
2021-12-13 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
7,018
-3.9%
46.72
327,881
USD
|
7,018
-3.9%
|
46.72
|
327,881
USD
|
|
2021-12-14 |
2021-12-13 |
PS
Planned sale
|
Valamehr Bahram
Chief R&D Officer
Officer
|
2,100
-1.2%
45.68
95,928
USD
|
2,100
-1.2%
|
45.68
|
95,928
USD
|
|
2021-12-13 |
2021-12-10 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
5
-0.0%
55.54
278
USD
|
5
-0.0%
|
55.54
|
278
USD
|
|
2021-12-13 |
2021-12-10 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
600
-0.5%
54.58
32,748
USD
|
600
-0.5%
|
54.58
|
32,748
USD
|
|
2021-12-13 |
2021-12-10 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
1,031
-0.8%
53.66
55,323
USD
|
1,031
-0.8%
|
53.66
|
55,323
USD
|
|
2021-12-13 |
2021-12-10 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
1,822
-1.4%
52.37
95,418
USD
|
1,822
-1.4%
|
52.37
|
95,418
USD
|
|
2021-12-13 |
2021-12-10 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
1,045
-0.8%
51.08
53,379
USD
|
1,045
-0.8%
|
51.08
|
53,379
USD
|
|
2021-12-13 |
2021-12-10 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
900
-0.7%
50.42
45,378
USD
|
900
-0.7%
|
50.42
|
45,378
USD
|
|
2021-12-13 |
2021-12-10 |
PS
Planned sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
2,097
-1.6%
49.32
103,424
USD
|
2,097
-1.6%
|
49.32
|
103,424
USD
|
|
2021-11-22 |
2021-11-18 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
20,000
-4.8%
54.27
1,085,400
USD
|
20,000
-4.8%
|
54.27
|
1,085,400
USD
|
|
2021-10-25 |
2021-10-22 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
30,000
-7.1%
58.88
1,766,400
USD
|
30,000
-7.1%
|
58.88
|
1,766,400
USD
|
|
2021-10-25 |
2021-10-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
14,765
-3.6%
60.63
895,202
USD
|
14,765
-3.6%
|
60.63
|
895,202
USD
|
|
2021-10-25 |
2021-10-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
15,235
-3.6%
59.82
911,358
USD
|
15,235
-3.6%
|
59.82
|
911,358
USD
|
|
2021-10-04 |
2021-10-01 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
11,844
-9.9%
59.68
706,862
USD
|
11,844
-9.9%
|
59.68
|
706,862
USD
|
|
2021-10-04 |
2021-10-01 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
21,844
-15.4%
58.96
1,287,966
USD
|
21,844
-15.4%
|
58.96
|
1,287,966
USD
|
|
2021-10-04 |
2021-10-01 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
16,312
-10.3%
58.03
946,634
USD
|
16,312
-10.3%
|
58.03
|
946,634
USD
|
|
2021-09-14 |
2021-09-13 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
800
-0.8%
67.46
53,965
USD
|
800
-0.8%
|
67.46
|
53,965
USD
|
|
2021-09-14 |
2021-09-13 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
8,391
-8.0%
66.84
560,879
USD
|
8,391
-8.0%
|
66.84
|
560,879
USD
|
|
2021-09-14 |
2021-09-13 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
15,809
-13.1%
65.94
1,042,414
USD
|
15,809
-13.1%
|
65.94
|
1,042,414
USD
|
|
2021-08-20 |
2021-08-19 |
S
Sale
|
Dulac Edward J III
Chief Financial Officer
Officer
|
63
-0.1%
90.00
5,670
USD
|
63
-0.1%
|
90.00
|
5,670
USD
|
|
2021-08-20 |
2021-08-19 |
S
Sale
|
Dulac Edward J III
Chief Financial Officer
Officer
|
1,474
-2.6%
88.65
130,670
USD
|
1,474
-2.6%
|
88.65
|
130,670
USD
|
|
2021-08-20 |
2021-08-19 |
S
Sale
|
Dulac Edward J III
Chief Financial Officer
Officer
|
1,937
-3.3%
87.90
170,262
USD
|
1,937
-3.3%
|
87.90
|
170,262
USD
|
|
2021-06-16 |
2021-06-14 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
400
-0.4%
90.76
36,303
USD
|
400
-0.4%
|
90.76
|
36,303
USD
|
|
2021-06-16 |
2021-06-14 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
8,220
-7.9%
89.68
737,155
USD
|
8,220
-7.9%
|
89.68
|
737,155
USD
|
|
2021-06-16 |
2021-06-14 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
16,380
-13.6%
89.11
1,459,587
USD
|
16,380
-13.6%
|
89.11
|
1,459,587
USD
|
|
2021-04-26 |
2021-04-23 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
30,000
-7.1%
85.24
2,557,284
USD
|
30,000
-7.1%
|
85.24
|
2,557,284
USD
|
|
2021-04-26 |
2021-04-22 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
30,000
-7.1%
85.54
2,566,212
USD
|
30,000
-7.1%
|
85.54
|
2,566,212
USD
|
|
2021-04-20 |
2021-04-16 |
S
Sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
1,500
-2.3%
84.41
126,615
USD
|
1,500
-2.3%
|
84.41
|
126,615
USD
|
|
2021-04-20 |
2021-04-16 |
S
Sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
900
-1.3%
82.91
74,619
USD
|
900
-1.3%
|
82.91
|
74,619
USD
|
|
2021-04-20 |
2021-04-16 |
S
Sale
|
Chu Yu-Waye
Senior VP Clinical Development
Officer
|
875
-1.3%
81.80
71,575
USD
|
875
-1.3%
|
81.80
|
71,575
USD
|
|
2021-03-16 |
2021-03-15 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
1,018
-1.1%
94.59
96,297
USD
|
1,018
-1.1%
|
94.59
|
96,297
USD
|
|
2021-03-16 |
2021-03-15 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
3,205
-3.2%
93.75
300,461
USD
|
3,205
-3.2%
|
93.75
|
300,461
USD
|
|
2021-03-16 |
2021-03-15 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
8,404
-7.8%
92.64
778,578
USD
|
8,404
-7.8%
|
92.64
|
778,578
USD
|
|
2021-03-16 |
2021-03-15 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
8,416
-7.2%
91.94
773,782
USD
|
8,416
-7.2%
|
91.94
|
773,782
USD
|
|
2021-03-16 |
2021-03-15 |
PS
Planned sale
|
Valamehr Bahram
Chief Development Officer
Officer
|
3,957
-3.3%
90.89
359,654
USD
|
3,957
-3.3%
|
90.89
|
359,654
USD
|
|
2021-03-09 |
2021-03-08 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
800
-1.1%
86.70
69,360
USD
|
800
-1.1%
|
86.70
|
69,360
USD
|
|
2021-03-09 |
2021-03-08 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
2,900
-3.8%
85.50
247,956
USD
|
2,900
-3.8%
|
85.50
|
247,956
USD
|
|
2021-03-09 |
2021-03-08 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
2,728
-3.4%
84.20
229,705
USD
|
2,728
-3.4%
|
84.20
|
229,705
USD
|
|
2021-03-09 |
2021-03-08 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
2,480
-3.0%
83.46
206,989
USD
|
2,480
-3.0%
|
83.46
|
206,989
USD
|
|
2021-03-09 |
2021-03-08 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
2,993
-3.5%
81.60
244,224
USD
|
2,993
-3.5%
|
81.60
|
244,224
USD
|
|
2021-03-09 |
2021-03-08 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
5,174
-5.7%
80.73
417,722
USD
|
5,174
-5.7%
|
80.73
|
417,722
USD
|
|
2021-03-09 |
2021-03-08 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
4,627
-4.9%
79.58
368,236
USD
|
4,627
-4.9%
|
79.58
|
368,236
USD
|
|
2021-03-09 |
2021-03-08 |
PS
Planned sale
|
Shoemaker Daniel D
Chief Scientific Officer
Officer
|
3,298
-3.4%
78.60
259,236
USD
|
3,298
-3.4%
|
78.60
|
259,236
USD
|
|
2021-02-19 |
2021-02-18 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
5,547
-1.4%
103.16
572,206
USD
|
5,547
-1.4%
|
103.16
|
572,206
USD
|
|
2021-02-19 |
2021-02-18 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
8,602
-2.1%
102.26
879,661
USD
|
8,602
-2.1%
|
102.26
|
879,661
USD
|
|
2021-02-19 |
2021-02-18 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
2,602
-0.6%
101.42
263,883
USD
|
2,602
-0.6%
|
101.42
|
263,883
USD
|
|
2021-02-19 |
2021-02-18 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
1,848
-0.4%
100.48
185,691
USD
|
1,848
-0.4%
|
100.48
|
185,691
USD
|
|
2021-02-19 |
2021-02-18 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
1,401
-0.3%
99.08
138,817
USD
|
1,401
-0.3%
|
99.08
|
138,817
USD
|
|
2021-01-22 |
2021-01-22 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
3,075
-0.8%
100.01
307,545
USD
|
3,075
-0.8%
|
100.01
|
307,545
USD
|
|
2021-01-22 |
2021-01-22 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
6,520
-1.6%
99.35
647,732
USD
|
6,520
-1.6%
|
99.35
|
647,732
USD
|
|
2021-01-22 |
2021-01-22 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
7,638
-1.9%
98.45
751,952
USD
|
7,638
-1.9%
|
98.45
|
751,952
USD
|
|
2021-01-22 |
2021-01-22 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
12,767
-3.0%
97.23
1,241,383
USD
|
12,767
-3.0%
|
97.23
|
1,241,383
USD
|
|
2021-01-22 |
2021-01-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
200
-0.1%
106.96
21,391
USD
|
200
-0.1%
|
106.96
|
21,391
USD
|
|
2021-01-22 |
2021-01-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
645
-0.2%
106.03
68,392
USD
|
645
-0.2%
|
106.03
|
68,392
USD
|
|
2021-01-22 |
2021-01-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
4,271
-1.1%
105.25
449,517
USD
|
4,271
-1.1%
|
105.25
|
449,517
USD
|
|
2021-01-22 |
2021-01-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
9,156
-2.2%
104.13
953,438
USD
|
9,156
-2.2%
|
104.13
|
953,438
USD
|
|
2021-01-22 |
2021-01-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
3,895
-0.9%
103.23
402,086
USD
|
3,895
-0.9%
|
103.23
|
402,086
USD
|
|
2021-01-22 |
2021-01-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
3,300
-0.8%
101.91
336,314
USD
|
3,300
-0.8%
|
101.91
|
336,314
USD
|
|
2021-01-22 |
2021-01-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
5,993
-1.4%
101.09
605,808
USD
|
5,993
-1.4%
|
101.09
|
605,808
USD
|
|
2021-01-22 |
2021-01-21 |
PS
Planned sale
|
Wolchko J Scott
President and CEO
Executive Director
|
2,540
-0.6%
100.16
254,411
USD
|
2,540
-0.6%
|
100.16
|
254,411
USD
|
|
2021-01-21 |
2021-01-19 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
200
-0.2%
117.07
23,413
USD
|
200
-0.2%
|
117.07
|
23,413
USD
|
|
2021-01-21 |
2021-01-19 |
PS
Planned sale
|
TAHL CINDY
General Counsel and Secretary
Officer
|
4,021
-4.3%
115.97
466,333
USD
|
4,021
-4.3%
|
115.97
|
466,333
USD
|
|